This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aurobindo Pharma Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Innovations of Gowrisankar Rao Kaki in Pharmaceutical Chemistry
Introduction
Gowrisankar Rao Kaki is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of processes for drug preparation. His work is characterized by a focus on innovative methods that enhance the efficiency and effectiveness of pharmaceutical compounds.
Latest Patents
One of his key patents is titled "Process for the preparation of Dolutegravir." This invention provides a method for synthesizing (R)-3-Amino-1-butanol (D)-tartarate and its conversion to Dolutegravir. The patent also outlines an improved process for preparing Dolutegravir or its pharmaceutically acceptable salts, wherein compound (XVI) is reacted with an optically active acid addition salt of (R)-3-amino-1-butanol.
Career Highlights
Gowrisankar Rao Kaki is associated with Aurobindo Pharma Limited, a prominent player in the pharmaceutical industry. His work at the company has been instrumental in advancing drug formulation techniques and improving the overall quality of pharmaceutical products. His dedication to innovation has positioned him as a valuable asset in the field.
Collaborations
Throughout his career, Gowrisankar has collaborated with esteemed colleagues, including Jagan Mohan Reddy Sanapureddy and Srinivasachary Katuroju. These collaborations have fostered a productive environment for research and development, leading to significant advancements in pharmaceutical sciences.
Conclusion
Gowrisankar Rao Kaki's contributions to pharmaceutical chemistry, particularly through his patent on Dolutegravir preparation, highlight his innovative spirit and commitment to improving drug development processes. His work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
